ResourceSpectroscopy

New Research Evaluating Cisplatin Uptake in Ovarian Cancer Cells by Single Cell ICP-MS

11 May 2017

Cisplatin is one of the most widely used platinum-based cancer chemotherapy drugs. Its effectiveness is due to its ability to bind to the cancers DNA, resulting in DNA-platinum adducts, which bends the DNA, resulting in a lack of DNA replication. Despite initial success, cisplatin drug resistance is common in relapse. This application note describes how SC-ICP-MS can be used to explore cellular uptake of cisplatin at the single cell level.

NexION 350 ICP-MS Spectrometers

PerkinElmer

When your instrument is more efficient and productive, so too are your scientists and your lab. And nothing puts the flow in your workflow better than the NexION® 350 ICP-MS. With a data acquisition speed 10 times faster than any other ICP-MS on the market, the new NexION 350 ICP-MS opens up a whole new world of efficiency and opportunity, allowing you to measure more in less time, and accurately characterize nanoparticles. In addition to the exceptional application flexibility afforded by its speed, the instrument also delivers superior uptime and productivity through a variety of unique features engineered to enhance signal stability: Triple Cone Interface produces the industry’s most tightly focused ion beam and prevents sample deposition on internal components. Quadrupole Ion Deflector turns positively charged ions 90° into the Universal Cell and filters off neutrals. Analyzing Quadrupole made of a unique steel alloy for negligible thermal expansion for unparalleled stability. No extraction lenses to clean for minimized maintenance.

(22)

Links

Tags

New Research Evaluating Cisplatin Uptake in Ovarian Cancer Cells by Single Cell ICP-MS